Frontier Medicines

Develops precision oncology drugs using chemoproteomics

Director/Senior Director, Quality Assurance - GCP/GMP

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours

Full-timeBoston, MA, USA

About the Job

Requirements

A bachelor's degree or higher in Chemistry, Pharmacy, Biochemistry, or a related scientific discipline.
At least 8 years of QA experience in the pharmaceutical or biotech industry, including at least 3 years in a leadership or senior management role in a clinical-stage setting.
Direct experience managing QA for small molecule drug development, including CMC/GMP oversight of chemical synthesis, solid-state formulation, and stability testing.
Robust expertise in global ICH GCP guidelines and strong working knowledge of phase-appropriate GMP regulations.
Strong familiarity with US FDA frameworks; experience with EU/EMA and Asian regulatory frameworks, such as PMDA and NMPA, is highly beneficial.
Experience implementing or managing a modern eQMS, such as Veeva Vault Quality, ZenQMS, or TrackWise.
Experience succeeding in a lean, fast-paced biotech environment that calls for a hybrid hands-on and high-level approach.
Legally authorized to work in the United States.

Responsibilities

Establish, maintain, and oversee the global GCP compliance strategy for Phase 1–2 clinical trials and prepare quality systems for upcoming registrational studies.
Lead qualification, selection, and routine auditing of CROs, clinical trial sites, central labs, and bioanalytical vendors across the US, EU, and Asia.
Design and execute the annual risk-based GCP audit plan, including investigator site, vendor, and internal process audits.
Review and approve critical clinical documents, including protocols, Investigator Brochures, Informed Consent Forms, and Clinical Study Reports.
Provide QA oversight of external CMOs handling small molecule API synthesis, solid-state formulation, packaging, and labeling.
Oversee review and phase-appropriate disposition of clinical trial material batches to ensure production meets global regulatory standards.
Negotiate, author, and maintain Quality Agreements with CMOs and critical raw material suppliers.
Partner with CMC to investigate manufacturing deviations, OOS results, and stability data anomalies as processes scale toward registration.
Maintain and continuously improve the eQMS so it scales from early clinical phases to commercial readiness.
Lead investigations into quality issues, deviations, and serious breaches, ensuring robust root-cause analysis and timely execution of CAPAs.
Author and execute a corporate inspection readiness roadmap for FDA (BIMO), EMA, and Asian regulatory agency inspections, and serve as primary QA host or back-room lead during inspections.

Director/Sr. Director, Quality Assurance (GCP/GMP)

Frontier Medicines · Boston, United States · Full-time · Posted 2026-10-22

Workplace: on_site

Department: CMC

Description

What’s in it for you?

Frontier Medicines is seeking a Director/Sr. Director, Quality Assurance to lead and scale our Quality Management System (QMS) as our small molecule pipeline advances from Phase 1/2 toward global registration over the next 2–3 years. This role will hold ultimate accountability for Good Clinical Practice (GCP) compliance across our global clinical trials while providing phase-appropriate Good Manufacturing Practice (GMP) oversight for our drug substance (API) and drug product programs.

Working in close partnership with Clinical Operations, CMC, and external partners, the Director will build the inspection readiness roadmap that bridges early-stage trials and commercial marketing authorization. The ideal candidate brings dual GCP/GMP expertise, deep small molecule experience, and a hands-on yet strategic mindset suited to a lean, fast-moving biotech environment.

Requirements

What will you be doing?

Establish, maintain, and oversee the global GCP compliance strategy for Phase 1–2 clinical trials, and prepare quality systems for upcoming registrational studies
Lead the qualification, selection, and routine auditing of CROs, clinical trial sites, central labs, and bioanalytical vendors across the US, EU, and Asia
Design and execute the annual risk-based GCP audit plan, including investigator site, vendor, and internal process audits
Review and approve critical clinical documents, including protocols, Investigator Brochures, Informed Consent Forms, and Clinical Study Reports
Provide QA oversight of external CMOs handling small molecule API synthesis, solid-state formulation, packaging, and labeling
Oversee review and phase-appropriate disposition of clinical trial material batches to ensure production meets global regulatory standards
Negotiate, author, and maintain Quality Agreements with CMOs and critical raw material suppliers
Partner with CMC to investigate manufacturing deviations, OOS results, and stability data anomalies as processes scale toward registration
Maintain and continuously improve the eQMS so it scales from early clinical phases to commercial readiness
Lead investigations into quality issues, deviations, and serious breaches, ensuring robust root-cause analysis and timely execution of CAPAs
Author and execute a corporate inspection readiness roadmap for FDA (BIMO), EMA, and Asian regulatory agency inspections, and serve as primary QA host or back-room lead during inspections

Traits we believe make a strong candidate:

Bachelor’s degree or higher in Chemistry, Pharmacy, Biochemistry, or a related scientific discipline
8+ years of QA experience in the pharmaceutical or biotech industry, including at least 3 years in a leadership or senior management role in a clinical-stage setting
Direct experience managing QA for small molecule drug development, including CMC/GMP oversight of chemical synthesis, solid-state formulation, and stability testing
Robust expertise in global ICH GCP guidelines alongside strong working knowledge of phase-appropriate GMP regulations
Strong familiarity with US FDA frameworks; experience with EU/EMA and Asian regulatory frameworks (e.g., PMDA, NMPA) is highly beneficial
Experience implementing or managing a modern eQMS (e.g., Veeva Vault Quality, ZenQMS, TrackWise)
Proven success in a lean, fast-paced biotech environment that calls for a hybrid hands-on and high-level approach
Strong communication and stakeholder management skills
Legally authorized to work in the United States

Benefits

Health Care Plan (Medical, Dental & Vision)
Retirement Plan (401k, IRA)
Life Insurance (Basic, Voluntary & AD&D)
Paid Time Off (Vacation, Sick & Public Holidays)
Family Leave (Maternity, Paternity)
Short Term & Long Term Disability
Training & Development
Free Food & Snacks
Wellness Resources
Stock Option Plan

At Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $200,000 - $275,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits.

This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.

Apply

Apply at Frontier Medicines

About the Company

Frontier Medicines

Develops precision oncology drugs using chemoproteomics

Frontier Medicines develops precision medicines for genetically defined patient populations, mainly in oncology and other hard-to-treat diseases. It uses chemoproteomics, covalent drug discovery, and machine learning to identify small molecules against difficult targets and advances candidates through clinical development toward commercialization. Its lead program FMC-376 targets KRAS G12C in both active and inactive states, and it has built the AutoTAC platform for targeted protein degradation to expand potential drug modalities. The company differentiates itself by combining genetics-driven target selection with advanced proteomics and chemistry within a platform approach that supports partnerships and licensing with larger pharma to bring therapies to patients.

Company size: 51-200
Company stage: Series C
Total funding: $255.5M
Headquarters: South San Francisco, CA
Founded: 2018

Recently Posted Jobs

Explore more opportunities at Frontier Medicines

See more jobs